Results 201 to 210 of about 91,887 (263)

Calcium channel blockers and Parkinson's disease: a systematic review and meta-analysis. [PDF]

Ther Adv Neurol Disord
Lin J, Pang D, Li C, Ou R, Yu Y, Cui Y, Huang J, Shang H.   +7 more
europepmc   +1 more source

Adverse Drug Reactions Associated with Concomitant Use of Calcium Channel Blockers and Cocaine: An Analysis of FDA Adverse Events Reporting System Data. [PDF]

J Clin Med
Chiappini S, Mosca A, Papanti Pelletier DG, Corkery JM, Guirguis A, Arillotta D, Martinotti G, Schifano F.   +7 more
europepmc   +1 more source

Inhibitory effects of calcium channel blockers nisoldipine and nimodipine on ivacaftor metabolism and their underlying mechanism. [PDF]

Front Pharmacol
Xia H, Xu X, Chen J, Wu H, Shen Y, Chen X, Xu RA, Wu W.   +7 more
europepmc   +1 more source

Corrigendum: Inhibitory effects of calcium channel blockers nisoldipine and nimodipine on ivacaftor metabolism and their underlying mechanism. [PDF]

Front Pharmacol
Xia H, Xu X, Chen J, Wu H, Shen Y, Chen X, Xu RA, Wu W.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Calcium Channel Blockers

AACN Advanced Critical Care, 1992
Calcium channel blockers are widely used in the treatment of ischemic heart disease, hypertension, and supraventricular tachycardia. The prototype agents, verapamil, nifedipine, and diltiazem, represent three classes of calcium channel blockers, each of which has different pharmacologic effects.
openaire   +2 more sources

Calcium channel blockers and calcium channels

2004
In 1883, Ringer showed that to get isolated hearts to contract, it was necessary to have Ca2+ ions in the perfusion medium [421]. This was the first demonstration of the critical role of calcium in cellular activity. Remarkably, a hundred years passed before the importance of calcium was recognized in processes other than muscle contraction, and almost
Eric Ertel, Théophile Godfraind
openaire   +1 more source

Calcium channel blockers and cancer

The American Journal of Medicine, 2000
We sought to explore the relation that has been previously reported between calcium channel blockers and an increased risk of cancer.We followed 3,511 participants, age 65 years or older, in the Duke Established Populations for Epidemiologic Studies of the Elderly for up to 10 years.
H J, Cohen, C F, Pieper, J T, Hanlon, W E, Wall, B M, Burchett, R J, Havlik   +5 more
openaire   +2 more sources

Calcium channel blockers: an update

The American Journal of Medicine, 2004
This paper reviews the current literature pertaining to calcium channel blockers, including their classification, properties, and therapeutic indications, in light of several recent trials that have addressed their safety. Calcium channel blockers are a structurally and functionally heterogeneous group of medications that are used widely to control ...
Mark J, Eisenberg, Anya, Brox, Alain N, Bestawros   +2 more
openaire   +2 more sources